Extracellular cholecystokinin levels in the rat spinal cord following chronic morphine exposure: an in vivo microdialysis study
- 1 March 1999
- journal article
- Published by Elsevier in Brain Research
- Vol. 821 (1) , 79-86
- https://doi.org/10.1016/s0006-8993(99)01068-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in ratsNeuroReport, 1994
- On the Origin of Striatal Cholecystokinin Release: Studies with In Vivo MicrodialysisJournal of Neurochemistry, 1994
- Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerancePain, 1991
- The role of CCK, caerulein, and CCK antagonists in nociceptionPain, 1989
- Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptorsLife Sciences, 1988
- Reversal of tolerance to morphine but no potentiation of morphine-induced analgesia by antiserum against cholecystokinin octapeptideNeuropharmacology, 1986
- Receptor‐receptor interactions in the central nervous system. A new integrative mechanism in synapsesMedicinal Research Reviews, 1985
- Evidence for Cholecystokinin‐Dopamine Receptor Interactions in the Central Nervous System of the Adult and Old RatAnnals of the New York Academy of Sciences, 1985
- Potentiation of Opiate Analgesia and Apparent Reversal of Morphine Tolerance by ProglumideScience, 1984
- Environmental modulation of analgesic tolerance induced by morphine pelletsPharmacology Biochemistry and Behavior, 1981